As of November 6, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of Vanda Pharmaceuticals Inc. The largest reported stake is Millennium Management LLC's, at 7%. 10 filings are on record since July 1, 2025 (Schedule 13G/A, October 9, 2026).
Sell to companies like Vanda Pharmaceuticals Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: BlackRock Portfolio Management LLC · Sole voting: 3,228,683 · Shared voting: 0 · Sole dispositive: 3,587,013 · Shared dispositive: 0 · SCHEDULE 13G, 2026-10-27
- · Reporting person: Millennium Management LLC · Sole voting: 0 · Shared voting: 4,260,038 · Sole dispositive: 0 · Shared dispositive: 4,260,038 · SCHEDULE 13G/A, 2026-10-09
- · Holder: Millennium Management LLC · Percent: 5.6% · SCHEDULE 13G
- · Reporting person: AQR Capital Management, LLC · Sole voting: 0 · Shared voting: 3,313,298 · Sole dispositive: 0 · Shared dispositive: 3,497,695 · SCHEDULE 13G, 2026-08-13
- · Holder: State Street Corporation · Percent: 5.1% · SCHEDULE 13G
Vanda Pharmaceuticals Inc. has 10 Schedule 13D or 13G filings on record since 2025-07-01. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Millennium Management LLC | 7% | 4,260,038 | SCHEDULE 13G/A, 2026-10-09 | 2026-09-30 |
| BlackRock Portfolio Management LLC | 5.9% | 3,587,013 | SCHEDULE 13G, 2026-10-27 | 2026-09-30 |
| AQR Capital Management, LLC | 5.82% | 3,497,695 | SCHEDULE 13G, 2026-08-13 | 2026-06-30 |
| State Street Corporation | 5.1% | 3,015,562 | SCHEDULE 13G, 2026-05-12 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Vanda Pharmaceuticals Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Vanda Pharmaceuticals Inc. and the records around it.
Vanda Pharmaceuticals Inc. elsewhere on the record
- Leadership changes Apr 2026
- Who owns it
Companies that share a holder
- BlackRock Portfolio Management LLC also filed stake reports on 118 other companies: AMERISAFE INC (Nov 2026), BlackRock ETF Trust (Nov 2026), iShares J.P. Morgan EM Local Currency Bond ETF (Nov 2026)
- Millennium Management LLC also filed stake reports on 121 other companies: StepStone Group Inc. (Nov 2026), Catalyst Acquisition Corp. (Nov 2026), RxSight, Inc. (Nov 2026)
- AQR Capital Management, LLC also filed stake reports on 190 other companies: Bold Eagle Acquisition Corp. (Nov 2026), Centurion Acquisition Corp. (Aug 2026), FG Merger II Corp. n/k/a BOXABL Inc. (Aug 2026)
Watch Vanda Pharmaceuticals Inc.
Get an email when Vanda Pharmaceuticals Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Vanda Pharmaceuticals Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vanda Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vanda Pharmaceuticals Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Millennium Management LLC | 0 | 4,260,038 | 0 | 4,260,038 | SCHEDULE 13G/A, 2026-10-09 |
| Millennium Group Management LLC | 0 | 4,260,038 | 0 | 4,260,038 | SCHEDULE 13G/A, 2026-10-09 |
| Israel A. Englander | 0 | 4,260,038 | 0 | 4,260,038 | SCHEDULE 13G/A, 2026-10-09 |
| BlackRock Portfolio Management LLC | 3,228,683 | 0 | 3,587,013 | 0 | SCHEDULE 13G, 2026-10-27 |
| AQR Capital Management, LLC | 0 | 3,313,298 | 0 | 3,497,695 | SCHEDULE 13G, 2026-08-13 |
| AQR Capital Management Holdings, LLC | 0 | 3,313,298 | 0 | 3,497,695 | SCHEDULE 13G, 2026-08-13 |
The latest filing identifies Vanda Pharmaceuticals Inc. by CUSIP 921659108 and gives its principal executive office as 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC 20037 (SCHEDULE 13G, 2026-10-27).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-01 | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2026-01-09 | Millennium Management LLC | 2.8% | SCHEDULE 13G/A |
| 2026-01-21 | BlackRock Portfolio Management LLC | 5.5% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-29 | BlackRock Portfolio Management LLC | 4.2% | SCHEDULE 13G/A |
| 2026-05-12 | State Street Corporation | 5.1% | SCHEDULE 13G |
| 2026-08-13 | AQR Capital Management, LLC | 5.82% | SCHEDULE 13G |
| 2026-08-19 | Millennium Management LLC | 5.6% | SCHEDULE 13G |
| 2026-10-09 | Millennium Management LLC | 7% | SCHEDULE 13G/A |
| 2026-10-27 | BlackRock Portfolio Management LLC | 5.9% | SCHEDULE 13G |
Questions about who owns Vanda Pharmaceuticals Inc.
Who owns Vanda Pharmaceuticals Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Vanda Pharmaceuticals Inc.: Millennium Management LLC (7%, Schedule 13G/A, filed 2026-10-09), BlackRock Portfolio Management LLC (5.9%, Schedule 13G, filed 2026-10-27), AQR Capital Management, LLC (5.82%, Schedule 13G, filed 2026-08-13) and State Street Corporation (5.1%, Schedule 13G, filed 2026-05-12).
Who are the largest shareholders of Vanda Pharmaceuticals Inc.?
By the share each holder's latest filing reports, the largest holders of Vanda Pharmaceuticals Inc. on this page are Millennium Management LLC (7%), BlackRock Portfolio Management LLC (5.9%) and AQR Capital Management, LLC (5.82%).
When did Millennium Management LLC buy into Vanda Pharmaceuticals Inc.?
The filings give report dates, not purchase dates. The earliest filing from Millennium Management LLC on this page is the Schedule 13G, filed 2025-07-01, reporting 5.3%; its latest, Schedule 13G/A filed 2026-10-09, reports 7%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Vanda Pharmaceuticals Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 22, 2026 | Leadership change: Charles C. Duncan appointed, Director | — | Leadership changes | Source |
| April 2, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Vanda Pharmaceuticals Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.